Nalmefene HCl Injection Now Available for Opioid Overdose Treatment
Pharmacodynamic studies have shown that nalmefene has a longer duration of action than naloxone.
Pharmacodynamic studies have shown that nalmefene has a longer duration of action than naloxone.
Investigators assessed outpatient opioid prescription practices among transgender and cisgender veterans.
Dsuvia, an opioid agonist, is a Schedule II controlled substance and is indicated for use in adults in a certified medically supervised healthcare setting.
The provision of multimodal nonopioid analgesia was linked to reduced subacute pain after total knee and hip arthroplasty.
Investigators sought to assess the effectiveness of SB5-adalimumab over 52 weeks in patients with Crohn disease after switching from originator-adalimumab.
Researchers sought to treat patients with dermatomyositis (DM) with baricitinib and investigate the results.
The aim of the study was to evaluate the prevalence of chronic pain disparities among the major racial and ethnic groups in the US.
Acupuncture therapy may effectively reduce opioid dependence in setting of acute pain.
Standardized initial settings for intravenous patient-controlled analgesia was linked to reduced opioid exposure in the first day after pancreatectomy.
Utilization of an online chronic pain management program was increased
during the COVID-19 pandemic.